4Life published a technical white paper entitled Clinical Study on Rapid Modulating Effects of 4Life Transfer Factor Max on Immune Stem Cells. Through two phases, the study analyzed the impact of 4Life Transfer Factor Max by administering the product or a placebo, then conducting a blood draw taken three times every hour.

4Life announced it has received a patent from the US Patent and Trademark Office (USPTO) for its RioVida line of products. The composition patent protects its nutraceutical food products that have a solid matrix and a liquid combined into a gel.

An independent study of 4Life Transfer Factor Lung will soon appear in the journal S China J P Med.